Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-02-01 to 2023-02-02
Current total value of award: $2443.5
Description: 4559857466!FASENRA 30 MG/ML SYRINGEML